Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT04674137
XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 16, 2020
Completion: Aug 27, 2021